- Investigator
- Philip A Efron
Clinical trials
-
Pathological Myeloid Activation After Sepsis and Trauma -
Dysfunctional Myelopoiesis and Myeloid-Derived Suppressor Cells in Sepsis Pathobiology - Investigator
- Philip A Efron
-
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia This phase II MyeloMATCH treatment trial compares the usual treatment of azacitidine and venetoclax to the combination treatment of azacitidine, venetoclax and gilteritinib in treating older and unfit patients with acute myeloid leukemia and FLT3…
- Investigator
- Dina Khalaf
- Ages
- 18 Years - N/A
- Sexes
- All